1p36 deletion is a marker for tumour dissemination in microsatellite stable stage II-III colon cancer

被引：0
|
作者：
Markus Mayrhofer
Hanna Göransson Kultima
Helgi Birgisson
Magnus Sundström
Lucy Mathot
Karolina Edlund
Björn Viklund
Tobias Sjöblom
Johan Botling
Patrick Micke
Lars Påhlman
Bengt Glimelius
Anders Isaksson
机构：
[1] Uppsala University,Science for Life Laboratory, Department of Medical Sciences
[2] Uppsala University,Department of Surgical Sciences
[3] Uppsala University,Science for Life Laboratory, Department of Immunology Genetics and Pathology
[4] Uppsala University,Department of Radiology, Oncology and Radiation Science
[5] Leibniz Research Centre for Working Environment and Human Factors,undefined
来源：
BMC Cancer | / 14卷
关键词：
Colon cancer; Prognostic marker; Allele-specific copy number analysis; Genome duplication; 1p36; Metastasis; Tumour dissemination;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Administration of adjuvant chemotherapy for stage II-III colon cancer patients: An European population-based study
    Babaei, Masoud
    Balavarca, Yesilda
    Jansen, Lina
    Lemmens, Valery
    van Erning, Felice N.
    van Eycken, Liesbet
    Vaes, Evelien
    Sjovall, Annika
    Glimelius, Bengt
    Ulrich, Cornelia M.
    Schrotz-King, Petra
    Brenner, Hermann
    INTERNATIONAL JOURNAL OF CANCER, 2018, 142 (07) : 1480 - 1489
  • [22] Identification of a Twelve-microRNA Signature with Prognostic Value in Stage II Microsatellite Stable Colon Cancer
    Moratalla-Navarro, Ferran
    Diez-Villanueva, Anna
    Garcia-Serrano, Ainhoa
    Closa, Adria
    Cordero, David
    Sole, Xavier
    Guino, Elisabet
    Sanz-Pamplona, Rebeca
    Sanjuan, Xavier
    Santos, Cristina
    Biondo, Sebastiano
    Salazar, Ramon
    Moreno, Victor
    CANCERS, 2023, 15 (13)
  • [23] Immunohistochemical assessment of tumour budding in stage II colon cancer-Bd0 as a prognostic marker
    Kristensen, M. Pihlmann
    Korsgaard, U.
    Timm, S.
    Hansen, T. Frostrup
    Zlobec, I.
    Kjaer-Frifeldt, S.
    Hager, H.
    VIRCHOWS ARCHIV, 2024, 485 : S159 - S159
  • [24] Thymidylate synthase (TS) expression as a prognostic molecular marker in stage II/III colon cancer
    Klingbiel, Dirk
    Missiaglia, Edoardo
    Yan, Pu
    Tejpar, Sabine
    Roth, Arnaud
    d'Ario, Giovanni
    Delorenzi, Mauro
    Bosman, Fred
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [25] Clinicopathological variables, immunophenotype, chromosome 1p36 loss and tumour recurrence of 247 meningiomas grade I and II
    Ruiz, Juan
    Martinez, Armando
    Hernandez, Susana
    Zimman, Horacio
    Ferrer, Milagros
    Fernandez, Cristina
    Saez, Mamen
    Lopez-Asenjo, Jose A.
    Sanz-Ortega, Julian
    HISTOLOGY AND HISTOPATHOLOGY, 2010, 25 (03) : 341 - 349
  • [26] Ubiquitin D is correlated with colon cancer progression and predicts recurrence for stage II-III disease after curative surgery
    Yan, D-W
    Li, D-W
    Yang, Y-X
    Xia, J.
    Wang, X-L
    Zhou, C-Z
    Fan, J-W
    Wen, Y-G
    Sun, H-C
    Wang, Q.
    Qiu, G-Q
    Tang, H-M
    Peng, Z-H
    BRITISH JOURNAL OF CANCER, 2010, 103 (07) : 961 - 969
  • [27] Prognostic relevance of estrogen receptor-α Ser167 phosphorylation in stage II-III colon cancer patients
    Lopez-Calderero, Iker
    Carnero, Amancio
    Astudillo, Aurora
    Palacios, Jose
    Chaves, Manuel
    Benavent, Marta
    Limon, Maria L.
    Garcia-Carbonero, Rocio
    HUMAN PATHOLOGY, 2014, 45 (12) : 2437 - 2446
  • [28] Elevated carbohydrate antigen 125 post-operation as a prognostic marker in gastric cancer patients with stage II-III
    Li, Jingjing
    Xu, Qi
    Luo, Cong
    Chen, Lei
    Ying, Jieer
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (09) : 5200 - 5208
  • [29] Prognostic Value of Combined Preoperative Carcinoembryonic Antigen and Prognostic Nutritional Index in Patients With Stage II-III Colon Cancer
    Xu, Yan-song
    Liu, Gang
    Zhao, Chang
    Lu, Shao-long
    Long, Chen-yan
    Zhong, Hua-ge
    Chen, Yi
    Huang, Ling-xu
    Liang, Zheng
    FRONTIERS IN SURGERY, 2021, 8
  • [30] Ubiquitin D is correlated with colon cancer progression and predicts recurrence for stage II-III disease after curative surgery
    D-W Yan
    D-W Li
    Y-X Yang
    J Xia
    X-L Wang
    C-Z Zhou
    J-W Fan
    Y-G Wen
    H-C Sun
    Q Wang
    G-Q Qiu
    H-M Tang
    Z-H Peng
    British Journal of Cancer, 2010, 103 : 961 - 969
12345